Back to Agenda
Session 2 - Points to Consider from Comparability of Cell Therapy
Session Chair(s)
![Kazuhiro Takekita](/_Images/member/Generic_Image_Missing-Profile.jpg)
Kazuhiro Takekita
Instructor, Department of Cardiovascular Surgery, Graduate School of Medicine,
Osaka University, Japan
Speaker(s)
![Kanako Watanabe, PhD](/_Images/member/Generic_Image_Missing-Profile.jpg)
Quality Aspects of Regenerative Medical Products
Kanako Watanabe, PhD
Pharmaceuticals and Medical Device Agency, Japan
Reviewer, Office of Cellular and Tissue-basaed Products
![Margarida Menezes-Ferreira, PhD](/_Images/member/Generic_Image_Missing-Profile.jpg)
Points to Consider on ATMPs’ Comparability Assessment on Manufacturing Change in Europe (Tentative)
Margarida Menezes-Ferreira, PhD
National Authority of Medicines and Health Products (INFARMED), Portugal
Scientific and Regulatory Advice Coordinator
![Kiwamu Imagawa, PhD](/_Images/member/Generic_Image_Missing-Profile.jpg)
Manufacturing Change Approach on Allogeneic Cell Therapy Products
Kiwamu Imagawa, PhD
JCR Pharmaceuticals Co., Ltd., Japan
Director, Regenerative Medicine, Research Division
Have an account?